Suzhou Highfine Biotech Co., Ltd.

XSEC:301393 Stock Report

Market Cap: CN¥5.2b

Suzhou Highfine Biotech Management

Management criteria checks 4/4

Suzhou Highfine Biotech's CEO is Yong Zhu, appointed in Jan 2016, has a tenure of 9.25 years. directly owns 47.86% of the company’s shares, worth CN¥2.48B. The average tenure of the management team and the board of directors is 9.3 years and 6.1 years respectively.

Key information

Yong Zhu

Chief executive officer

CN¥642.1k

Total compensation

CEO salary percentagen/a
CEO tenure9.3yrs
CEO ownership47.9%
Management average tenure9.3yrs
Board average tenure6.1yrs

Recent management updates

Recent updates


CEO

Yong Zhu (53 yo)

9.3yrs

Tenure

CN¥642,100

Compensation

Mr. Yong Zhu is Chairman & GM of Suzhou Highfine Biotech Co. Ltd. from January 5, 2016.


Leadership Team

NamePositionTenureCompensationOwnership
Yong Zhu
Chairman & GM9.3yrsCN¥642.10k47.86%
CN¥ 2.5b
Xiaoyan Wang
Finance Manager & Accounting Supervisor21.2yrsCN¥259.40kno data
Xu Jie
Director & Deputy GM9.3yrsCN¥560.80k4.89%
CN¥ 253.2m
Minjie Lv
Director & Deputy GM9.3yrsCN¥543.40k1.86%
CN¥ 96.5m
Xuegen Lu
Director & Deputy GM9.3yrsCN¥528.50k1.86%
CN¥ 96.4m
Shengjun Dong
Deputy GM & Secretary of the Board5.1yrsCN¥455.90k2.03%
CN¥ 105.2m

9.3yrs

Average Tenure

44.5yo

Average Age

Experienced Management: 301393's management team is seasoned and experienced (9.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yong Zhu
Chairman & GM9.3yrsCN¥642.10k47.86%
CN¥ 2.5b
Xu Jie
Director & Deputy GM9.3yrsCN¥560.80k4.89%
CN¥ 253.2m
Minjie Lv
Director & Deputy GM9.3yrsCN¥543.40k1.86%
CN¥ 96.5m
Xuegen Lu
Director & Deputy GM9.3yrsCN¥528.50k1.86%
CN¥ 96.4m
Jinfeng Li
Supervisor6.1yrsno datano data
Yu Luo
Director3.8yrsCN¥607.30kno data
Qizhu Sun
Director6.1yrsCN¥475.10kno data
Haoyi Sun
Chairman of the Supervisory Board6.1yrsno datano data
Xiangguo Cai
Employee Representative Supervisor6.2yrsno datano data
Qing Wang
Independent Director3.8yrsCN¥72.00kno data
Xiaoping Xu
Independent Director3.8yrsCN¥72.00kno data
Jiahui Yu
Independent Director1.7yrsCN¥30.00kno data

6.1yrs

Average Tenure

46yo

Average Age

Experienced Board: 301393's board of directors are considered experienced (6.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/26 03:46
End of Day Share Price 2025/04/25 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Suzhou Highfine Biotech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd